Cerebral ischemia is a common cerebrovascular disease, and its treatment goals are to restore brain blood flow as soon as possible, reduce brain tissue damage, and prevent recurrence. At Protheragen, our anti-cerebral ischemia APIs effectively protect brain tissue from ischemia-reperfusion injury through multiple mechanisms such as improving brain microcirculation, inhibiting platelet aggregation, reducing oxidative stress and neuroinflammation.

Protheragen offers a full range of anti-cerebral ischemia APIs to support our customers' research worldwide.